UK markets close in 56 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
11.88+0.01 (+0.08%)
As of 10:34AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5552.04M
Enterprise value 3497.12M
Trailing P/E N/A
Forward P/E 1-5.53
PEG ratio (5-yr expected) 10.06
Price/sales (ttm)6.95
Price/book (mrq)4.34
Enterprise value/revenue 36.26
Enterprise value/EBITDA 6-3.11

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3-45.25%
S&P500 52-week change 314.33%
52-week high 326.26
52-week low 310.80
50-day moving average 313.76
200-day moving average 315.61

Share statistics

Avg vol (3-month) 3877.08k
Avg vol (10-day) 3850.55k
Shares outstanding 546.47M
Float 42.92M
% held by insiders 12.08%
% held by institutions 1131.45%
Shares short (14 Jul 2020) 48.05M
Short ratio (14 Jul 2020) 411.34
Short % of float (14 Jul 2020) 423.91%
Short % of shares outstanding (14 Jul 2020) 417.33%
Shares short (prior month 14 Jun 2020) 49.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020


Profit margin -252.92%
Operating margin (ttm)-230.90%

Management effectiveness

Return on assets (ttm)-33.92%
Return on equity (ttm)-125.73%

Income statement

Revenue (ttm)79.38M
Revenue per share (ttm)1.74
Quarterly revenue growth (yoy)87.40%
Gross profit (ttm)42.29M
EBITDA -159.66M
Net income avi to common (ttm)-200.76M
Diluted EPS (ttm)-4.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)264.73M
Total cash per share (mrq)5.7
Total debt (mrq)210.28M
Total debt/equity (mrq)165.30
Current ratio (mrq)4.28
Book value per share (mrq)2.74

Cash flow statement

Operating cash flow (ttm)-143.61M
Levered free cash flow (ttm)-90.7M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more